{
    "2020-05-28": [
        [
            {
                "time": "",
                "original_text": "锁定翻倍大牛股：浮盈最高逾216% 公募参与定增规模突增548%",
                "features": {
                    "keywords": [
                        "翻倍",
                        "牛股",
                        "浮盈",
                        "公募",
                        "定增",
                        "规模突增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-06-02",
                "original_text": "康泰生物：97.4万股限售股6月2日上市流通 解禁",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "限售股",
                        "解禁",
                        "上市流通"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-06-02",
                "original_text": "康泰生物(300601.SZ)：97.44万股限制性股票6月2日解禁 解禁",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "限制性股票",
                        "解禁"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}